Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04789382 · ClinicalTrials.gov registry record · NA

Three Daily Wear Monthly Replacement Silicone Hydrogel Contact Lenses With Two Multi-purpose Disinfecting Solution Combinations

A NA study of Refractive Errors, sponsored by Alcon Research.

Completed
Registry status
NA
Development phase
36
Enrollment target
1
Study location

NCT04789382 is a NA study of Refractive Errors that has completed, run by Alcon Research. The registered enrollment target is 36 participants, below the 104-participant average among 14 other Refractive Errors trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04789382, a NA study of Refractive Errors, has completed, sponsored by Alcon Research.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate corneal staining observed after 2 hours of wear with an investigational contact lens against both PureVision contact lenses pre-cycled with Biotrue and Biofinity contact lenses pre-cycled with RepleniSH.

Conditions Studied

Interventions

  • DEVICE LID018869+RepleniSH
  • DEVICE LID018869+Biotrue
  • DEVICE Biofinity+RepleniSH
  • DEVICE PV+Biotrue

Study Locations (1)

Florida

  • Alcon Investigator 6565 - Maitland

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2021-04-07
Est. Completion 2021-05-07
Phase NA

Sponsor

Alcon Research

275 total trials

What the Registry Record Tells You About NCT04789382

The ClinicalTrials.gov registry entry for NCT04789382 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 104-participant average among 14 other Refractive Errors trials with a reported enrollment target (65% lower). The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Refractive Errors appearing as the primary indexed condition, and to 4 interventions - of which LID018869+RepleniSH is the first listed.

NCT04789382 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT04789382 about?

NCT04789382 is a clinical study titled "Three Daily Wear Monthly Replacement Silicone Hydrogel Contact Lenses With Two Multi-purpose Disinfecting Solution Combinations". The purpose of this study is to evaluate corneal staining observed after 2 hours of wear with an investigational contact lens against both PureVision contact lenses pre-cycled with Biotrue and Biofinity contact lenses pre-cycled with RepleniSH.

What is the current status of trial NCT04789382?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2021-04-07. Estimated completion is 2021-05-07.

What conditions does trial NCT04789382 study?

This clinical trial studies the following conditions: Refractive Errors.

What interventions are being tested in trial NCT04789382?

The interventions under investigation include: LID018869+RepleniSH (DEVICE), LID018869+Biotrue (DEVICE), Biofinity+RepleniSH (DEVICE), PV+Biotrue (DEVICE).

Who is sponsoring clinical trial NCT04789382?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04789382 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Refractive Errors

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.